This study tests a combination of two experimental drugs (AGEN1423 and botensilimab) with or without standard chemotherapy in people with advanced pancreatic cancer that has worsened after at least one prior treatment. The goal is to see if the combination can shrink tumors or sl…
Phase: PHASE2 • Sponsor: Bruno Bockorny • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC